![Peter Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Smith
Direttore/Membro del Consiglio presso RYVU THERAPEUTICS S.A.
Profilo
Peter Smith is the founder of Remix Therapeutics, Inc., Amplify Medicines, Inc. He is currently working as an Advisor at Atlas Venture Advisors, Inc. since 2018 and as a Member-Supervisory Board at Ryvu Therapeutics SA since 2023.
Previously, he worked as the Chief Scientific Officer at H3 Biomedicine, Inc. from 2011 to 2018.
Dr. Smith obtained a doctorate degree from Newcastle University in 2000 and an undergraduate degree from the University of Sheffield Medical School in 1996.
Posizioni attive di Peter Smith
Società | Posizione | Inizio |
---|---|---|
RYVU THERAPEUTICS S.A. | Direttore/Membro del Consiglio | 14/06/2023 |
Remix Therapeutics, Inc.
![]() Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Amministratore Delegato | 17/08/2021 |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consulente / Consigliere | 01/01/2018 |
Amplify Medicines, Inc.
![]() Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Part of Ikena Oncology, Inc., Amplify Medicines, Inc. develops pharmaceutical drugs. The company is based in Boston, MA. The company was founded by Peter Smith. | Fondatore | - |
Precedenti posizioni note di Peter Smith
Società | Posizione | Fine |
---|---|---|
H3 Biomedicine, Inc.
![]() H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Corporate Officer/Principal | 31/12/2018 |
Formazione di Peter Smith
Newcastle University | Doctorate Degree |
University of Sheffield Medical School | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
RYVU THERAPEUTICS S.A. | Health Technology |
Aziende private | 4 |
---|---|
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
H3 Biomedicine, Inc.
![]() H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
Remix Therapeutics, Inc.
![]() Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Health Technology |
Amplify Medicines, Inc.
![]() Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Part of Ikena Oncology, Inc., Amplify Medicines, Inc. develops pharmaceutical drugs. The company is based in Boston, MA. The company was founded by Peter Smith. | Health Technology |
- Borsa valori
- Insiders
- Peter Smith